Report

  1. Home
  2. Healthcare
  3. Biotechnology

Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, Gene Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Data Analysis), Application (Drug discovery & Development, Clinical Diagnostics), End User, and Region - Global Forecast to 2031

Market Report I 2026-04-15 I 511 Pages I MarketsandMarkets

The gene expression analysis market is expected to reach USD 5.93 billion in 2031 from USD 4.23 billion in 2026, at a CAGR of 7.0% during the forecast period. The market is driven by the increasing adoption of transcriptomics technologies and the growing focus on precision medicine and personalized therapeutics. Techniques such as next-generation sequencing, PCR, and microarrays enable accurate and high-throughput analysis of gene activity, supporting advancements in disease research and diagnostics. Furthermore, the rising use of gene expression profiling in biomarker discovery and drug development enhances research efficiency and clinical outcomes. However, high instrument costs, complex data analysis, and the need for skilled professionals continue to limit market growth.

https://mnmimg.marketsandmarkets.com/Images/gene-expression-analysis-market-img-overview.webp

"The reagents & consumables segment is expected to grow at the highest CAGR during the forecast period."
The reagents & consumables segment is projected to grow at the highest CAGR in the gene expression analysis market due to the repeated and high-volume usage of kits, enzymes, probes, and other consumables across research and clinical workflows. These products are essential for techniques such as PCR, next-generation sequencing, and microarray analysis, ensuring consistent demand. The increasing number of genomics and transcriptomics studies, along with the rising adoption of gene expression profiling in diagnostics and drug research, is further driving segment growth. Additionally, continuous product innovations and the need for reliable and high-quality reagents to ensure accurate results contribute to the expansion of this segment. Their cost-effectiveness and recurring purchase nature make reagents & consumables a key growth driver in the market.

"Drug discovery & development segment holds the largest share of the market."
The drug discovery & development segment accounts for the largest share of the gene expression analysis market, driven by the extensive use of gene expression profiling in identifying and validating drug targets. These technologies play a critical role in understanding gene function, disease pathways, and therapeutic responses, thereby improving the efficiency of drug development processes. Pharmaceutical and biotechnology companies increasingly rely on gene expression analysis for biomarker discovery, toxicity assessment, and efficacy evaluation. The growing focus on precision medicine and targeted therapies, along with rising R&D investments, further supports the dominance of this segment.
"The US is projected to grow at the highest CAGR during the forecast period."
The US is projected to grow at the highest CAGR in the gene expression analysis market due to its strong presence of leading biotechnology and pharmaceutical companies, advanced research infrastructure, and increasing focus on genomics and transcriptomics studies. Rising adoption of gene expression profiling in areas such as oncology, genetic disorders, and precision medicine is a key factor driving market growth. Technologies including next-generation sequencing, PCR, and microarrays are widely used across research and clinical applications, further boosting demand. Additionally, supportive regulatory frameworks, high funding for genomic research, and continuous advancements in analytical technologies contribute to market expansion.
The primary interviews conducted for this report can be categorized as follows:

- By Respondent: Supply Side - 70% and Demand Side - 30%
- By Designation: Managers - 45%, CXOs and Directors - 30%, and Executives - 25%
- By Region: North America - 40%, Europe - 25%, Asia Pacific - 25%, Latin America - 5%, the Middle East & Africa - 5%
Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), PacBio (US), Agilent Technologies, Inc. (US), Sysmex Corporation (Japan), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc. (Japan), Danaher Corporation (US), Bruker (US), 10X Genomics (US), Zymo Research Corporation (US), Twist Bioscience (US), Promega Corporation (US), LGC Limited (UK), CD Genomics (US), BioSpyder Technologies Inc. (US), and New England Biolabs (US) are some of the key companies offering gene expression analysis products & services.

Research Coverage
This research report categorizes the gene expression analysis market by offering (reagents & consumables[assays & kits, enzymes, DNA chips, other reagents & consumables], instruments [PCR, NGS, DNA microarray, other instruments], services [gene expression analysis services{RNA sequencing services, other services}, bioinformatics solutions]), application (drug discovery & development, clinical diagnostics, other applications), end user (pharmaceutical & biotechnology companies, academic & research institutes, other end users), and region (North America, Europe, Asia Pacific, Latin America, Middle East, And Africa).
The report's scope encompasses detailed information about the primary factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the gene expression analysis market. A comprehensive analysis of key industry players has been performed to provide insights into their business overview, product portfolio, key strategies, new product launches, acquisitions, and recent developments related to the gene expression analysis market. This report also includes a competitive analysis of emerging startups in the gene expression analysis industry ecosystem.
Key Benefits of Buying the Report
The report will assist market leaders and new entrants by providing revenue estimates for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses effectively and develop suitable go-to-market strategies. This report will enable stakeholders to grasp the market's pulse and offer information on key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (growing use of gene expression analysis in drug discovery and development, expanding applications in disease research, and rising adoption of gene expression-based diagnostics and prognostics tests), restraints (High cost of instruments and complexity of data analysis and interpretation), opportunities (growing adoption of single-cell analysis technologies and expansion of gene expression analysis in clinical and translational research), and challenges (lack of standardization) influencing the market growth
- Product Development/Innovation: Detailed insights into newly launched products and innovations in the gene expression analysis market
- Market Development: Comprehensive information about lucrative markets and analysis of the market across varied regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the gene expression analysis market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and products & services of leading players, Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), PacBio (US), Agilent Technologies, Inc. (US), Sysmex Corporation (Japan), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc. (Japan), among others, for the gene expression analysis market

1 INTRODUCTION 44
1.1 STUDY OBJECTIVES 44
1.2 MARKET DEFINITION 44
1.3 STUDY SCOPE 44
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 45
1.3.2 INCLUSIONS & EXCLUSIONS 46
1.3.3 YEARS CONSIDERED 46
1.3.4 CURRENCY CONSIDERED 47
1.4 STAKEHOLDERS 47
1.5 SUMMARY OF CHANGES 47
2 EXECUTIVE SUMMARY 49
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 49
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 50
2.3 DISRUPTIVE TRENDS IN GENE EXPRESSION ANALYSIS MARKET 51
2.4 HIGH-GROWTH SEGMENTS 52
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 53
3 PREMIUM INSIGHTS 54
3.1 GENE EXPRESSION ANALYSIS MARKET OVERVIEW 54
3.2 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING 55
3.3 GENE EXPRESSION ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
3.4 GENE EXPRESSION ANALYSIS MARKET SHARE, BY OFFERING, 2026 VS 2031 (%) 56
4 MARKET OVERVIEW 57
4.1 INTRODUCTION 57
4.2 MARKET DYNAMICS 58
4.2.1 DRIVERS 59
4.2.1.1 Growing use of gene expression analysis in drug discovery and development 59
4.2.1.2 Expanding applications in disease research 59
4.2.1.3 Rising adoption of gene expression-based diagnostics and prognostics tests 60
4.2.2 RESTRAINTS 60
4.2.2.1 High cost of instruments 60
4.2.2.2 Complexity of data analysis and interpretation 61
4.2.3 OPPORTUNITIES 61
4.2.3.1 Growing adoption of single-cell analysis technologies 61
4.2.3.2 Expansion of gene expression analysis in clinical and translational research 62
4.2.4 CHALLENGES 62
4.2.4.1 Lack of standardization 62
4.3 UNMET NEEDS AND WHITE SPACES 63
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 63
4.5 STRATEGIC MOVIES BY TIER-1/2/3 PLAYERS 64
5 INDUSTRY TRENDS 65
5.1 PORTER'S FIVE FORCES ANALYSIS 65
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 66
5.1.2 BARGAINING POWER OF SUPPLIERS 66
5.1.3 BARGAINING POWER OF BUYERS 67
5.1.4 THREAT OF SUBSTITUTES 67
5.1.5 THREAT OF NEW ENTRANTS 67
5.2 MACROECONOMIC OUTLOOK 67
5.2.1 INTRODUCTION 67
5.2.2 GDP TRENDS AND FORECAST 67
5.2.3 R&D TRENDS IN GLOBAL HEALTHCARE INDUSTRY 68
5.2.4 R&D TRENDS IN GLOBAL BIOTECH INDUSTRY 68
5.3 VALUE CHAIN ANALYSIS 68
5.4 ECOSYSTEM ANALYSIS 70
5.4.1 ROLE OF PLAYERS IN ECOSYSTEM 71
5.5 PRICING ANALYSIS 72
5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025 (USD) 73
5.5.1.1 Instruments 73
5.5.1.2 Consumables 74
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025 (USD) 75
5.5.2.1 Instruments 75
5.5.2.2 Consumables 76
5.6 TRADE ANALYSIS 77
5.6.1 IMPORT SCENARIO (HS CODE 3822.00) 77
5.6.2 EXPORT SCENARIO (HS CODE 3822.00) 78
5.6.3 IMPORT SCENARIO (HS CODE 9027.00) 79
5.6.4 EXPORT SCENARIO (HS CODE 9027.00) 80
5.7 KEY CONFERENCES & EVENTS, 2026-2027 81
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 81
5.9 INVESTMENT & FUNDING SCENARIO 82
5.10 CASE STUDY ANALYSIS 83
5.10.1 RNA SEQUENCING ENABLES CLINICAL DIAGNOSTIC ADVANCEMENTS IN RARE GENETIC DISORDERS 83
5.10.2 TRANSCRIPTOMIC PROFILING IMPROVES BIOMARKER DETECTION IN ONCOLOGY 83
5.10.3 GENE EXPRESSION ANALYSIS ENABLES FUNCTIONAL INTERPRETATION IN RARE DISEASE DIAGNOSTICS 84
5.11 IMPACT OF US TARIFFS-GENE EXPRESSION ANALYSIS MARKET 84
5.11.1 INTRODUCTION 84
5.11.2 KEY TARIFF RATES 84
5.11.3 PRICE IMPACT ANALYSIS 85
5.11.4 IMPACT ON COUNTRIES/REGIONS 86
5.11.4.1 US 86
5.11.4.2 Europe 86
5.11.4.3 Asia Pacific 87
5.11.5 IMPACT ON END-USE INDUSTRIES 87
5.11.5.1 Pharmaceutical & biotechnology companies 87
5.11.5.2 CROs and academic & research institutes 87
5.11.5.3 Clinical laboratories 88
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 89
6.1 INTRODUCTION 89
6.2 KEY TECHNOLOGIES 89
6.2.1 QUANTITATIVE PCR (QPCR) 89
6.2.2 MICROARRAY TECHNOLOGY 89
6.2.3 RNA SEQUENCING 90
6.3 ADJACENT TECHNOLOGIES 90
6.3.1 SINGLE-CELL ANALYSIS 90
6.3.2 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 90
6.3.3 SPATIAL BIOLOGY 91
6.4 TECHNOLOGY ROADMAP 91
6.5 PATENT ANALYSIS 92
6.5.1 METHODOLOGY 92
6.5.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE 92
6.5.3 LIST OF KEY PATENTS 94
6.6 FUTURE APPLICATIONS 95
6.7 IMPACT OF AI/GEN AI ON GENE EXPRESSION ANALYSIS MARKET 95
6.7.1 TOP USE CASES AND MARKET POTENTIAL 96
6.7.2 BEST PRACTICES IN AI-ENABLED GENE EXPRESSION WORKFLOWS 97
6.7.3 CASE STUDIES RELATED TO AI IMPLEMENTATION IN GENE EXPRESSION ANALYSIS MARKET 97
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 97
6.7.5 CLIENTS' READINESS TO ADOPT AI-INTEGRATED GENERATIVE MOLECULAR DESIGN IN GENE EXPRESSION ANALYSIS MARKET 98
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 99
7.1 REGIONAL REGULATIONS AND COMPLIANCE 99
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
7.1.2 INDUSTRY STANDARDS 101
7.1.2.1 North America 101
7.1.2.2 Europe 102
7.1.2.3 Asia Pacific 102
7.1.2.4 Rest of the world 102
7.1.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 103
7.2 SUSTAINABILITY INITIATIVES 104
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 105
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 106
8.1 DECISION-MAKING PROCESS 106
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 106
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 106
8.2.2 BUYING CRITERIA 107
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 108
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 108
9 GENE EXPRESSION ANALYSIS MARKET, BY OFFERING 110
9.1 INTRODUCTION 111
9.2 REAGENTS & CONSUMABLES 111
9.2.1 ASSAYS & KITS 115
9.2.1.1 Rising adoption of multi-omics and single-cell assay kits to drive market 115
9.2.1.2 RNA isolation kits 119
9.2.1.2.1 Increasing demand for high-quality RNA and integrated multi-omics workflows to drive market 119
9.2.1.3 cDNA synthesis kits 123
9.2.1.3.1 Growing demand for high-fidelity reverse transcription in advanced transcriptomics to drive market 123
9.2.1.4 Library preparation kits 126
9.2.1.4.1 Increasing adoption of high-throughput sequencing and multiomics workflows to drive market 126
9.2.1.5 PCR assays & kits 130
9.2.1.5.1 Expanding use of PCR-integrated workflows in diagnostics and precision medicine to drive market 130
9.2.1.6 Other assays & kits 133
9.2.2 ENZYMES 136
9.2.2.1 Advancements in high-fidelity, application-specific enzymes to drive market 136
9.2.3 DNA CHIPS 140
9.2.3.1 Increasing adoption of high-throughput DNA chips in large-scale genomics research to propel market 140
9.2.4 OTHER REAGENTS & CONSUMABLES 143
9.3 INSTRUMENTS 147
9.3.1 PCR INSTRUMENTS 150
9.3.1.1 Increasing adoption of high-precision and automated PCR technologies to boost demand 150
9.3.2 NGS INSTRUMENTS 153
9.3.2.1 Expanding adoption of high-throughput NGS platforms to drive market 153
9.3.3 DNA MICROARRAY SCANNERS 156
9.3.3.1 Enhanced microarray performance and throughput to propel market 156
9.3.4 OTHER INSTRUMENTS 160
9.4 SOFTWARE & SERVICES 163
9.4.1 GENE EXPRESSION ANALYSIS SERVICES 167
9.4.1.1 RNA sequencing services 171
9.4.1.1.1 Expanding transcriptomics research to propel market 171
9.4.1.2 Microarray analysis services 174
9.4.1.2.1 Increasing demand for standardized, high-throughput gene expression profiling in large-sample studies to propel market 174
9.4.1.3 qPCR profiling services 178
9.4.1.3.1 Increasing demand for precise gene expression quantification to propel market 178
9.4.1.4 Other gene expression analysis services 181
9.4.2 BIOINFORMATICS SOLUTIONS 185
9.4.2.1 Rising demand for AI-driven bioinformatics solutions to support market growth 185
9.4.2.2 Bioinformatics & data analysis services 189
9.4.2.2.1 Rising complexity of multi-omics data and demand for AI-driven biological insights to drive market 189
9.4.2.3 Software 192
9.4.2.3.1 Gene expression databases 195
9.4.2.3.1.1 Increasing need for structured data management to drive market 195
9.4.2.3.2 Data analysis software & visualization tools 198
9.4.2.3.2.1 Increasing demand for simplified data analysis and effective visualization of complex gene expression datasets to drive market 198
9.4.2.3.3 Cloud-based analysis platforms 202
9.4.2.3.3.1 Increasing shift toward AI-enabled SaaS cloud ecosystems to drive market 202
10 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION 205
10.1 INTRODUCTION 206
10.2 DRUG DISCOVERY & DEVELOPMENT 206
10.2.1 INCREASING AI-INTEGRATED TRANSCRIPTOMICS AND PRECISION MEDICINE TO PROPEL MARKET 206
10.3 CLINICAL DIAGNOSTICS 210
10.3.1 INTEGRATION OF AI-DRIVEN ANALYSIS AND ADVANCED MOLECULAR DIAGNOSTICS TO DRIVE MARKET 210
10.4 BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS 213
10.4.1 EXPANDING MULTI-OMICS RESEARCH AND AI-ENABLED BIOINFORMATICS PLATFORMS TO DRIVE MARKET 213
10.5 OTHER APPLICATIONS 217
11 GENE EXPRESSION ANALYSIS MARKET, BY END USER 220
11.1 INTRODUCTION 221
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 221
11.2.1 STRATEGIC PHARMA-TECH COLLABORATIONS TO DRIVE MARKET 221
11.3 ACADEMIC & RESEARCH INSTITUTES 225
11.3.1 EXPANSION OF OPEN-ACCESS GENOMIC RESOURCES TO PROPEL MARKET 225
11.4 HOSPITALS & CLINICAL LABORATORIES 228
11.4.1 INTEGRATION OF PRECISION ONCOLOGY TO PROPEL MARKET 228
11.5 CONTRACT RESEARCH ORGANIZATIONS (CROS) 232
11.5.1 INCREASING OUTSOURCING OF COMPLEX GENOMIC RESEARCH AND CLINICAL TRIALS TO PROPEL MARKET 232
11.6 OTHER END USERS 235
12 GENE EXPRESSION ANALYSIS MARKET, BY REGION 239
12.1 INTRODUCTION 240
12.2 NORTH AMERICA 240
12.2.1 US 247
12.2.1.1 Rapid adoption of spatial transcriptomics and advanced genomics platforms to drive market 247
12.2.2 CANADA 252
12.2.2.1 Increasing incidence of chronic diseases to drive market 252
12.3 EUROPE 258
12.3.1 GERMANY 263
12.3.1.1 Expanding genomics infrastructure and advanced bioinformatics platforms to drive market 263
12.3.2 UK 268
12.3.2.1 National genomics initiatives and large-scale multiomics research to drive market 268
12.3.3 FRANCE 273
12.3.3.1 Increasing R&D in life sciences research to fuel market 273
12.3.4 ITALY 278
12.3.4.1 Expanding precision medicine research and adoption of advanced sequencing technologies to support market growth 278
12.3.5 SPAIN 283
12.3.5.1 Large-scale genomics programs to boost demand 283
12.3.6 REST OF EUROPE 288
12.4 ASIA PACIFIC 293
12.4.1 CHINA 299
12.4.1.1 Large-scale genomics program to boost demand 299
12.4.2 JAPAN 304
12.4.2.1 Integration of AI-driven genomics and precision oncology to propel market 304
12.4.3 INDIA 309
12.4.3.1 Expansion of national genomic databases to drive market 309
12.4.4 AUSTRALIA 314
12.4.4.1 National genomics integration to drive market 314
12.4.5 SOUTH KOREA 319
12.4.5.1 Government-led genomic data initiatives to boost demand 319
12.4.6 REST OF ASIA PACIFIC 324
12.5 LATIN AMERICA 329
12.5.1 BRAZIL 334
12.5.1.1 Growth in the biopharmaceutical industry to support market 334
12.5.2 MEXICO 339
12.5.2.1 Increasing incidence of diabetes and growing geriatric population to propel market 339
12.5.3 REST OF LATIN AMERICA 344
12.6 MIDDLE EAST 349
12.6.1 GCC COUNTRIES 353
12.6.1.1 Saudi Arabia 358
12.6.1.1.1 National genomics strategies and precision medicine integration to support market growth 358
12.6.1.2 United Arab Emirates 363
12.6.1.2.1 NGS-driven collaborations to fuel market 363
12.6.1.3 Rest of GCC Countries 368
12.6.2 REST OF MIDDLE EAST 373
12.7 AFRICA 378
12.7.1 EXPANDING GENOMICS RESEARCH CAPACITY AND DISEASE-FOCUSED INITIATIVES TO SUPPORT MARKET GROWTH 378
13 COMPETITIVE LANDSCAPE 384
13.1 INTRODUCTION 384
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 384
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GENE EXPRESSION ANALYSIS MARKET, JANUARY 2023-MARCH 2026 384
13.3 REVENUE ANALYSIS, 2021-2025 386
13.4 MARKET SHARE ANALYSIS, 2025 387
13.5 BRAND COMPARISON 390
13.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 391
13.6.1 STARS 391
13.6.2 EMERGING LEADERS 391
13.6.3 PERVASIVE PLAYERS 391
13.6.4 PARTICIPANTS 391
13.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 393
13.6.5.1 Company footprint 393
13.6.5.2 Region footprint 394
13.6.5.3 Offering footprint 395
13.6.5.4 Application footprint 396
13.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 397
13.7.1 PROGRESSIVE COMPANIES 397
13.7.2 RESPONSIVE COMPANIES 397
13.7.3 DYNAMIC COMPANIES 397
13.7.4 STARTING BLOCKS 397
13.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 399
13.7.5.1 Detailed list of key startups/SMEs 399
13.7.5.2 Competitive benchmarking of key startups/SMEs 400
13.8 COMPANY VALUATION & FINANCIAL METRICS 401
13.8.1 COMPANY VALUATION 401
13.8.2 FINANCIAL METRICS 401
13.9 COMPETITIVE SCENARIO 402
13.9.1 PRODUCT LAUNCHES 402
13.9.2 DEALS 403
13.9.3 EXPANSIONS 403
14 COMPANY PROFILES 404
14.1 KEY PLAYERS 404
14.1.1 THERMO FISHER SCIENTIFIC INC. 404
14.1.1.1 Business overview 404
14.1.1.2 Products/Services offered 405
14.1.1.3 Recent developments 409
14.1.1.3.1 Product launches 409
14.1.1.3.2 Deals 410
14.1.1.3.3 Expansions 410
14.1.1.4 MnM view 410
14.1.1.4.1 Key strengths 410
14.1.1.4.2 Strategic choices 411
14.1.1.4.3 Weaknesses and competitive threats 411
14.1.2 BIO-RAD LABORATORIES, INC. 412
14.1.2.1 Business overview 412
14.1.2.2 Products/Services offered 414
14.1.2.3 Recent developments 417
14.1.2.3.1 Product launches 417
14.1.2.3.2 Deals 418
14.1.2.4 MnM view 418
14.1.2.4.1 Key strengths 418
14.1.2.4.2 Strategic choices 418
14.1.2.4.3 Weaknesses and competitive threats 418
14.1.3 ILLUMINA, INC. 419
14.1.3.1 Business overview 419
14.1.3.2 Products/Services offered 420
14.1.3.3 Recent developments 423
14.1.3.3.1 Product launches 423
14.1.3.3.2 Deals 424
14.1.3.4 MnM view 424
14.1.3.4.1 Key strengths 424
14.1.3.4.2 Strategic choices 424
14.1.3.4.3 Weaknesses and competitive threats 424
14.1.4 QIAGEN 425
14.1.4.1 Business overview 425
14.1.4.2 Products/Services offered 426
14.1.4.3 Recent developments 431
14.1.4.3.1 Product launches 431
14.1.4.3.2 Deals 431
14.1.4.4 MnM view 432
14.1.4.4.1 Key strengths 432
14.1.4.4.2 Strategic choices 432
14.1.4.4.3 Weaknesses and competitive threats 432
14.1.5 REVVITY 433
14.1.5.1 Business overview 433
14.1.5.2 Products/Services offered 434
14.1.5.3 Recent developments 436
14.1.5.3.1 Deals 436
14.1.5.3.2 Expansions 436
14.1.5.4 MnM view 436
14.1.5.4.1 Key strengths 436
14.1.5.4.2 Strategic choices 436
14.1.5.4.3 Weaknesses and competitive threats 437
14.1.6 F. HOFFMANN-LA ROCHE LTD. 438
14.1.6.1 Business overview 438
14.1.6.2 Products/Services offered 439
14.1.6.3 Recent developments 440
14.1.6.3.1 Product launches 440
14.1.6.3.2 Deals 441
14.1.6.3.3 Other developments 441
14.1.7 PACBIO 442
14.1.7.1 Business overview 442
14.1.7.2 Products/Services offered 443
14.1.7.3 Recent developments 444
14.1.7.3.1 Product launches 444
14.1.7.3.2 Deals 444
14.1.7.3.3 Expansions 445
14.1.8 AGILENT TECHNOLOGIES, INC. 446
14.1.8.1 Business overview 446
14.1.8.2 Products/Services offered 447
14.1.9 SYSMEX CORPORATION 451
14.1.9.1 Business overview 451
14.1.9.2 Products/Services offered 452
14.1.9.3 Recent developments 453
14.1.9.3.1 Deals 453
14.1.9.3.2 Other developments 453
14.1.10 BGI 454
14.1.10.1 Business overview 454
14.1.10.2 Products/Services offered 454
14.1.11 EUROFINS SCIENTIFIC 456
14.1.11.1 Business overview 456
14.1.11.2 Products/Services offered 457
14.1.12 STANDARD BIOTOOLS 458
14.1.12.1 Business overview 458
14.1.12.2 Products/Services offered 459
14.1.12.3 Recent developments 460
14.1.12.3.1 Product launches 460
14.1.13 OXFORD NANOPORE TECHNOLOGIES PLC 461
14.1.13.1 Business overview 461
14.1.13.2 Products/Services offered 462
14.1.13.3 Recent developments 463
14.1.13.3.1 Deals 463
14.1.13.3.2 Expansions 464
14.1.14 GENSCRIPT 465
14.1.14.1 Business overview 465
14.1.14.2 Products/Services offered 466
14.1.14.3 Recent developments 467
14.1.14.3.1 Deals 467
14.1.14.3.2 Expansions 467
14.1.15 TAKARA BIO INC. 468
14.1.15.1 Business overview 468
14.1.15.2 Products/Services offered 469
14.1.15.3 Recent developments 473
14.1.15.3.1 Product launches 473
14.1.15.3.2 Deals 474
14.1.16 DANAHER CORPORATION 475
14.1.16.1 Business overview 475
14.1.16.2 Products/Services offered 476
14.1.16.3 Recent developments 476
14.1.16.3.1 Deals 476
14.1.17 BRUKER 477
14.1.17.1 Business overview 477
14.1.17.2 Products/Services offered 479
14.1.17.3 Recent developments 479
14.1.17.3.1 Deals 479
14.2 OTHER PLAYERS 480
14.2.1 10X GENOMICS 480
14.2.2 ZYMO RESEARCH CORPORATION 481
14.2.3 TWIST BIOSCIENCE 482
14.2.4 PROMEGA CORPORATION 483
14.2.5 LGC LIMITED 485
14.2.6 CD GENOMICS 486
14.2.7 BIOSPYDER TECHNOLOGIES INC. 487
14.2.8 NEW ENGLAND BIOLABS 488
15 RESEARCH METHODOLOGY 491
15.1 RESEARCH DATA 491
15.1.1 SECONDARY DATA 492
15.1.1.1 Key data from secondary sources 492
15.1.2 PRIMARY DATA 493
15.1.2.1 Key data from primary sources 493
15.1.2.2 Key primary participants 493
15.1.2.3 Breakdown of primary interviews 493
15.1.2.4 Key industry insights 494
15.2 MARKET SIZE ESTIMATION 495
15.2.1 GLOBAL GENE EXPRESSION ANALYSIS MARKET ESTIMATION, 2025 495
15.2.2 SEGMENTAL MARKET SIZE ESTIMATION 498
15.3 MARKET GROWTH RATE PROJECTIONS 499
15.4 DATA TRIANGULATION 500
15.5 FACTOR ANALYSIS 501
15.6 RESEARCH ASSUMPTIONS 501
15.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT 502
16 APPENDIX 503
16.1 DISCUSSION GUIDE 503
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 507
16.3 CUSTOMIZATION OPTIONS 509
16.4 RELATED REPORTS 509
16.5 AUTHOR DETAILS 510

TABLE 1 GENE EXPRESSION ANALYSIS MARKET: INCLUSIONS AND EXCLUSIONS 46
TABLE 2 GENE EXPRESSION ANALYSIS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 58
TABLE 3 GENE EXPRESSION ANALYSIS MARKET: PORTER'S FIVE FORCES 65
TABLE 4 GENE EXPRESSION ANALYSIS MARKET: ROLE OF PLAYERS IN ECOSYSTEM 71
TABLE 5 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2023-2025 (USD) 73
TABLE 6 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2023-2025 (USD) 74
TABLE 7 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2023-2025 (USD) 75
TABLE 8 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY REGION, 2023-2025 (USD) 76
TABLE 9 IMPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND) 77
TABLE 10 EXPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND) 78
TABLE 11 IMPORT DATA FOR HS CODE 9027.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND) 79
TABLE 12 EXPORT DATA FOR HS CODE 9027.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND) 80
TABLE 13 GENE EXPRESSION ANALYSIS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026-MARCH 2027 81
TABLE 14 RECIPROCAL TARIFF RATES ADJUSTED BY US 84
TABLE 15 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 86
TABLE 16 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015-2025 92
TABLE 17 LIST OF KEY PATENTS IN GENE EXPRESSION ANALYSIS MARKET, 2023-2025 94
TABLE 18 CASE STUDIES OF AI IMPLEMENTATION IN GENE EXPRESSION ANALYSIS MARKET 97
TABLE 19 CLIENT'S READINESS TO ADOPT AI-INTEGRATED GENERATIVE MOLECULAR DESIGN IN GENE EXPRESSION ANALYSIS MARKET 98
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 107
TABLE 25 KEY BUYING CRITERIA, BY END USER 107
TABLE 26 GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 111
TABLE 27 GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 112
TABLE 28 GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION) 112
TABLE 29 NORTH AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 113
TABLE 30 EUROPE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 113
TABLE 31 ASIA PACIFIC: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 114
TABLE 32 LATIN AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 114
TABLE 33 MIDDLE EAST: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION) 115
TABLE 34 GCC COUNTRIES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 115
TABLE 35 GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 116
TABLE 36 NORTH AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 116
TABLE 37 EUROPE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 117
TABLE 38 ASIA PACIFIC: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 117
TABLE 39 LATIN AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 118
TABLE 40 MIDDLE EAST: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 118
TABLE 41 GCC COUNTRIES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 118
TABLE 42 GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 119
TABLE 43 RNA ISOLATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 120
TABLE 44 NORTH AMERICA: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 120
TABLE 45 EUROPE: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 121
TABLE 46 ASIA PACIFIC: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 121
TABLE 47 LATIN AMERICA: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 122
TABLE 48 MIDDLE EAST: RNA ISOLATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 122
TABLE 49 GCC COUNTRIES: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 122
TABLE 50 CDNA SYNTHESIS KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 123
TABLE 51 NORTH AMERICA: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 124
TABLE 52 EUROPE: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 124
TABLE 53 ASIA PACIFIC: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 125
TABLE 54 LATIN AMERICA: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 125
TABLE 55 MIDDLE EAST: CDNA SYNTHESIS KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 125
TABLE 56 GCC COUNTRIES: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 126
TABLE 57 LIBRARY PREPARATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 127
TABLE 58 NORTH AMERICA: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 127
TABLE 59 EUROPE: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 128
TABLE 60 ASIA PACIFIC: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 128
TABLE 61 LATIN AMERICA: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 129
TABLE 62 MIDDLE EAST: LIBRARY PREPARATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 129
TABLE 63 GCC COUNTRIES: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 129
TABLE 64 PCR ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 130
TABLE 65 NORTH AMERICA: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 131
TABLE 66 EUROPE: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 131
TABLE 67 ASIA PACIFIC: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 132
TABLE 68 LATIN AMERICA: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 132
TABLE 69 MIDDLE EAST: PCR ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 132
TABLE 70 GCC COUNTRIES: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 133
TABLE 71 OTHER ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 133
TABLE 72 NORTH AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 134
TABLE 73 EUROPE: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 134
TABLE 74 ASIA PACIFIC: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 135
TABLE 75 LATIN AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 135
TABLE 76 MIDDLE EAST: OTHER ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION) 135
TABLE 77 GCC COUNTRIES: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 136
TABLE 78 GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY REGION, 2024-2031 (USD MILLION) 137
TABLE 79 NORTH AMERICA: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 137
TABLE 80 EUROPE: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 138
TABLE 81 ASIA PACIFIC: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 138
TABLE 82 LATIN AMERICA: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 139
TABLE 83 MIDDLE EAST: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY REGION, 2024-2031 (USD MILLION) 139
TABLE 84 GCC COUNTRIES: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 139
TABLE 85 GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY REGION, 2024-2031 (USD MILLION) 140
TABLE 86 NORTH AMERICA: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 141
TABLE 87 EUROPE: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 141
TABLE 88 ASIA PACIFIC: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 142
TABLE 89 LATIN AMERICA: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 142
TABLE 90 MIDDLE EAST: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY REGION, 2024-2031 (USD MILLION) 143
TABLE 91 GCC COUNTRIES: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 143
TABLE 92 OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION) 144
TABLE 93 NORTH AMERICA: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 144
TABLE 94 EUROPE: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 145
TABLE 95 ASIA PACIFIC: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 145
TABLE 96 LATIN AMERICA: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 146
TABLE 97 MIDDLE EAST: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION) 146
TABLE 98 GCC COUNTRIES: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 146
TABLE 99 GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION) 147
TABLE 100 NORTH AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 147
TABLE 101 EUROPE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 148
TABLE 102 ASIA PACIFIC: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 148
TABLE 103 LATIN AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 149
TABLE 104 MIDDLE EAST: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION) 149
TABLE 105 GCC COUNTRIES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 149
TABLE 106 GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 150
TABLE 107 PCR INSTRUMENT MARKET, BY REGION, 2024-2031 (USD MILLION) 151
TABLE 108 NORTH AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 151
TABLE 109 EUROPE: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 151
TABLE 110 ASIA PACIFIC: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 152
TABLE 111 LATIN AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 152
TABLE 112 MIDDLE EAST: PCR INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION) 152
TABLE 113 GCC COUNTRIES: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 153
TABLE 114 NGS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION) 154
TABLE 115 NORTH AMERICA: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 154
TABLE 116 EUROPE: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 154
TABLE 117 ASIA PACIFIC: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 155
TABLE 118 LATIN AMERICA: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 155
TABLE 119 MIDDLE EAST: NGS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION) 155
TABLE 120 GCC COUNTRIES: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 156
TABLE 121 DNA MICROARRAY SCANNERS MARKET, BY REGION, 2024-2031 (USD MILLION) 157
TABLE 122 NORTH AMERICA: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 157
TABLE 123 EUROPE: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 158
TABLE 124 ASIA PACIFIC: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 158
TABLE 125 LATIN AMERICA: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 159
TABLE 126 MIDDLE EAST: DNA MICROARRAY SCANNERS MARKET, BY REGION 2024-2031 (USD MILLION) 159
TABLE 127 GCC COUNTRIES: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 159
TABLE 128 OTHER INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION) 160
TABLE 129 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 160
TABLE 130 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 161
TABLE 131 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 161
TABLE 132 LATIN AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 162
TABLE 133 MIDDLE EAST: OTHER INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION) 162
TABLE 134 GCC COUNTRIES: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 162
TABLE 135 GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 163
TABLE 136 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 164
TABLE 137 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 164
TABLE 138 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 165
TABLE 139 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 165
TABLE 140 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 166
TABLE 141 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 166
TABLE 142 GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 166
TABLE 143 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 167
TABLE 144 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 168
TABLE 145 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 168
TABLE 146 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 169
TABLE 147 LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 169
TABLE 148 MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 170
TABLE 149 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 170
TABLE 150 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 170
TABLE 151 RNA SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 171
TABLE 152 NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 172
TABLE 153 EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 172
TABLE 154 ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 173
TABLE 155 LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 173
TABLE 156 MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 174
TABLE 157 GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 174
TABLE 158 MICROARRAY ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 175
TABLE 159 NORTH AMERICA: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 175
TABLE 160 EUROPE: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 176
TABLE 161 ASIA PACIFIC: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 176
TABLE 162 LATIN AMERICA: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 177
TABLE 163 MIDDLE EAST: MICROARRAY ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 177
TABLE 164 GCC COUNTRIES: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 177
TABLE 165 QPCR PROFILING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 178
TABLE 166 NORTH AMERICA: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 179
TABLE 167 EUROPE: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 179
TABLE 168 ASIA PACIFIC: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 180
TABLE 169 LATIN AMERICA: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 180
TABLE 170 MIDDLE EAST: QPCR PROFILING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 181
TABLE 171 GCC COUNTRIES: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 181
TABLE 172 OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 182
TABLE 173 NORTH AMERICA: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 182
TABLE 174 EUROPE: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 183
TABLE 175 ASIA PACIFIC: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 183
TABLE 176 LATIN AMERICA: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 184
TABLE 177 MIDDLE EAST: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 184
TABLE 178 GCC COUNTRIES: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 184
TABLE 179 GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY REGION, 2024-2031 (USD MILLION) 185
TABLE 180 NORTH AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 186
TABLE 181 EUROPE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 186
TABLE 182 ASIA PACIFIC: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 187
TABLE 183 LATIN AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 187
TABLE 184 MIDDLE EAST: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY REGION, 2024-2031 (USD MILLION) 188
TABLE 185 GCC COUNTRIES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 188
TABLE 186 GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 188
TABLE 187 GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 189
TABLE 188 NORTH AMERICA: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 189
TABLE 189 EUROPE: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 190
TABLE 190 ASIA PACIFIC: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 190
TABLE 191 LATIN AMERICA: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 191
TABLE 192 MIDDLE EAST: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION) 191
TABLE 193 GCC COUNTRIES: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 191
TABLE 194 GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY REGION, 2024-2031 (USD MILLION) 192
TABLE 195 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 192
TABLE 196 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 193
TABLE 197 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 193
TABLE 198 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 194
TABLE 199 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY REGION, 2024-2031 (USD MILLION) 194
TABLE 200 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 194
TABLE 201 GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 195
TABLE 202 GENE EXPRESSION DATABASES MARKET, BY REGION, 2024-2031 (USD MILLION) 195
TABLE 203 NORTH AMERICA: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 196
TABLE 204 EUROPE: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 196
TABLE 205 ASIA PACIFIC: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 197
TABLE 206 LATIN AMERICA: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 197
TABLE 207 MIDDLE EAST: GENE EXPRESSION DATABASES MARKET, BY REGION, 2024-2031 (USD MILLION) 198
TABLE 208 GCC COUNTRIES: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 198
TABLE 209 GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY REGION, 2024-2031 (USD MILLION) 199
TABLE 210 NORTH AMERICA: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 199
TABLE 211 EUROPE: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 200
TABLE 212 ASIA PACIFIC: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 200
TABLE 213 LATIN AMERICA: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 201
TABLE 214 MIDDLE EAST: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY REGION, 2024-2031 (USD MILLION) 201
TABLE 215 GCC COUNTRIES: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 201
TABLE 216 CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION) 202
TABLE 217 NORTH AMERICA: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 202
TABLE 218 EUROPE: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 203
TABLE 219 ASIA PACIFIC: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 203
TABLE 220 LATIN AMERICA: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 204
TABLE 221 MIDDLE EAST: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION) 204
TABLE 222 GCC COUNTRIES: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 204
TABLE 223 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 206
TABLE 224 GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION) 207
TABLE 225 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION) 207
TABLE 226 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION) 208
TABLE 227 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION) 208
TABLE 228 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION) 209
TABLE 229 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION) 209
TABLE 230 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION) 209
TABLE 231 GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2024-2031 (USD MILLION) 210
TABLE 232 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION) 211
TABLE 233 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION) 211
TABLE 234 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION) 212
TABLE 235 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION) 212
TABLE 236 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2024-2031 (USD MILLION) 213
TABLE 237 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION) 213
TABLE 238 GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY REGION, 2024-2031 (USD MILLION) 214
TABLE 239 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION) 214
TABLE 240 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION) 215
TABLE 241 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION) 215
TABLE 242 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION) 216
TABLE 243 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY REGION, 2024-2031 (USD MILLION) 216
TABLE 244 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION) 216
TABLE 245 GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION) 217
TABLE 246 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION) 217
TABLE 247 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION) 218
TABLE 248 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION) 218
TABLE 249 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION) 219
TABLE 250 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION) 219
TABLE 251 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION) 219
TABLE 252 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 221
TABLE 253 GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION) 222
TABLE 254 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION) 222
TABLE 255 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION) 223
TABLE 256 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION) 223
TABLE 257 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION) 224
TABLE 258 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION) 224
TABLE 259 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION) 224
TABLE 260 GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION) 225
TABLE 261 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION) 226
TABLE 262 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION) 226
TABLE 263 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION) 227
TABLE 264 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION) 227
TABLE 265 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION) 228
TABLE 266 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION) 228
TABLE 267 GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024-2031 (USD MILLION) 229
TABLE 268 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION) 229
TABLE 269 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION) 230
TABLE 270 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION) 230
TABLE 271 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION) 231
TABLE 272 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024-2031 (USD MILLION) 231
TABLE 273 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION) 231
TABLE 274 GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION) 232
TABLE 275 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION) 233
TABLE 276 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION) 233
TABLE 277 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION) 234
TABLE 278 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION) 234
TABLE 279 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION) 235
TABLE 280 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION) 235
TABLE 281 GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION) 236
TABLE 282 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION) 236
TABLE 283 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION) 237
TABLE 284 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION) 237
TABLE 285 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION) 238
TABLE 286 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION) 238
TABLE 287 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION) 238
TABLE 288 GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION) 240
TABLE 289 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 241
TABLE 290 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 242
TABLE 291 NORTH AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 242
TABLE 292 NORTH AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 243
TABLE 293 NORTH AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 243
TABLE 294 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 244
TABLE 295 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 244
TABLE 296 NORTH AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 245
TABLE 297 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 245
TABLE 298 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 246
TABLE 299 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 246
TABLE 300 US: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 247
TABLE 301 US: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 248
TABLE 302 US: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 248
TABLE 303 US: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 249
TABLE 304 US: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 249
TABLE 305 US: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 250
TABLE 306 US: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 250
TABLE 307 US: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 251
TABLE 308 US: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 251
TABLE 309 US: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 252

TABLE 310 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 253
TABLE 311 CANADA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 253
TABLE 312 CANADA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 254
TABLE 313 CANADA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 254
TABLE 314 CANADA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 255
TABLE 315 CANADA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 255
TABLE 316 CANADA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 256
TABLE 317 CANADA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 256
TABLE 318 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 257
TABLE 319 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 257
TABLE 320 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 258
TABLE 321 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 258
TABLE 322 EUROPE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 259
TABLE 323 EUROPE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 259
TABLE 324 EUROPE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 260
TABLE 325 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 260
TABLE 326 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 261
TABLE 327 EUROPE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 261
TABLE 328 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 262
TABLE 329 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 262
TABLE 330 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 263
TABLE 331 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 264
TABLE 332 GERMANY: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 264
TABLE 333 GERMANY: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 265
TABLE 334 GERMANY: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 265
TABLE 335 GERMANY: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 266
TABLE 336 GERMANY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 266
TABLE 337 GERMANY: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 266
TABLE 338 GERMANY: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 267
TABLE 339 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 267
TABLE 340 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 268
TABLE 341 UK: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 269
TABLE 342 UK: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 269
TABLE 343 UK: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 269
TABLE 344 UK: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 270
TABLE 345 UK: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 270
TABLE 346 UK: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 271
TABLE 347 UK: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 271
TABLE 348 UK: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 272
TABLE 349 UK: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 272
TABLE 350 UK: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 273
TABLE 351 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 274
TABLE 352 FRANCE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 274
TABLE 353 FRANCE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 275
TABLE 354 FRANCE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 275
TABLE 355 FRANCE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 276
TABLE 356 FRANCE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 276
TABLE 357 FRANCE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 276
TABLE 358 FRANCE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 277
TABLE 359 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 277
TABLE 360 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 278
TABLE 361 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 279
TABLE 362 ITALY: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 279
TABLE 363 ITALY: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 279
TABLE 364 ITALY: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 280
TABLE 365 ITALY: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 280
TABLE 366 ITALY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 281
TABLE 367 ITALY: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 281
TABLE 368 ITALY: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 282
TABLE 369 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 282
TABLE 370 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 283
TABLE 371 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 284
TABLE 372 SPAIN: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 284
TABLE 373 SPAIN: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 284
TABLE 374 SPAIN: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 285
TABLE 375 SPAIN: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 285
TABLE 376 SPAIN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 286
TABLE 377 SPAIN: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 286
TABLE 378 SPAIN: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 287
TABLE 379 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 287
TABLE 380 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 288
TABLE 381 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 289
TABLE 382 REST OF EUROPE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 289
TABLE 383 REST OF EUROPE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 289
TABLE 384 REST OF EUROPE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 290
TABLE 385 REST OF EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 290
TABLE 386 REST OF EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 291
TABLE 387 REST OF EUROPE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 291
TABLE 388 REST OF EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 292
TABLE 389 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 292
TABLE 390 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 293
TABLE 391 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION) 294
TABLE 392 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 295
TABLE 393 ASIA PACIFIC: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 295
TABLE 394 ASIA PACIFIC: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 296
TABLE 395 ASIA PACIFIC: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 296
TABLE 396 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 297
TABLE 397 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 297
TABLE 398 ASIA PACIFIC: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 297
TABLE 399 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 298
TABLE 400 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 298
TABLE 401 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 299
TABLE 402 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 300
TABLE 403 CHINA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 300
TABLE 404 CHINA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 300
TABLE 405 CHINA GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 301
TABLE 406 CHINA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 301
TABLE 407 CHINA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 302
TABLE 408 CHINA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 302
TABLE 409 CHINA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 303
TABLE 410 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 303
TABLE 411 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 304
TABLE 412 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 305
TABLE 413 JAPAN: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 305
TABLE 414 JAPAN: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 306
TABLE 415 JAPAN: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 306
TABLE 416 JAPAN: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 307
TABLE 417 JAPAN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 307
TABLE 418 JAPAN: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 307
TABLE 419 JAPAN: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 308
TABLE 420 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 308
TABLE 421 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 309
TABLE 422 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 310
TABLE 423 INDIA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 310
TABLE 424 INDIA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 310
TABLE 425 INDIA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 311
TABLE 426 INDIA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 311
TABLE 427 INDIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 312
TABLE 428 INDIA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 312
TABLE 429 INDIA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 313
TABLE 430 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 313
TABLE 431 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 314
TABLE 432 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 315
TABLE 433 AUSTRALIA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 315
TABLE 434 AUSTRALIA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 316
TABLE 435 AUSTRALIA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 316
TABLE 436 AUSTRALIA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 317
TABLE 437 AUSTRALIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 317
TABLE 438 AUSTRALIA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 317
TABLE 439 AUSTRALIA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 318
TABLE 440 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 318
TABLE 441 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 319
TABLE 442 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 320
TABLE 443 SOUTH KOREA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 320
TABLE 444 SOUTH KOREA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 320
TABLE 445 SOUTH KOREA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 321
TABLE 446 SOUTH KOREA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 321
TABLE 447 SOUTH KOREA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 322
TABLE 448 SOUTH KOREA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 322
TABLE 449 SOUTH KOREA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 323
TABLE 450 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 323
TABLE 451 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 324
TABLE 452 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 325
TABLE 453 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 325
TABLE 454 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 325
TABLE 455 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 326
TABLE 456 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 326
TABLE 457 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 327
TABLE 458 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 327
TABLE 459 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 328
TABLE 460 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 328
TABLE 461 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 329
TABLE 462 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION) 330
TABLE 463 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 330
TABLE 464 LATIN AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 330
TABLE 465 LATIN AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 331
TABLE 466 LATIN AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 331
TABLE 467 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 332
TABLE 468 LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 332
TABLE 469 LATIN AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 332
TABLE 470 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 333
TABLE 471 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 333
TABLE 472 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 334
TABLE 473 BRAZIL: GENE EXPRESSION ANALYSIS MARKET BY OFFERING, 2024-2031 (USD MILLION) 335
TABLE 474 BRAZIL: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 335
TABLE 475 BRAZIL: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 336
TABLE 476 BRAZIL: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 336
TABLE 477 BRAZIL: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 337
TABLE 478 BRAZIL: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 337
TABLE 479 BRAZIL: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 337
TABLE 480 BRAZIL: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 338
TABLE 481 BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 338
TABLE 482 BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 339
TABLE 483 MEXICO: GENE EXPRESSION ANALYSIS MARKET BY OFFERING, 2024-2031 (USD MILLION) 340
TABLE 484 MEXICO: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 340
TABLE 485 MEXICO: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 341
TABLE 486 MEXICO: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 341
TABLE 487 MEXICO: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 342
TABLE 488 MEXICO: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 342
TABLE 489 MEXICO: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 342
TABLE 490 MEXICO: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 343
TABLE 491 MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 343
TABLE 492 MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 344
TABLE 493 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 345
TABLE 494 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 345
TABLE 495 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 345
TABLE 496 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 346
TABLE 497 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 346
TABLE 498 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 347
TABLE 499 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 347
TABLE 500 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 348
TABLE 501 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 348
TABLE 502 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 349
TABLE 503 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION) 349
TABLE 504 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 350
TABLE 505 MIDDLE EAST: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 350
TABLE 506 MIDDLE EAST: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 350
TABLE 507 MIDDLE EAST: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 351
TABLE 508 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 351
TABLE 509 MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 351
TABLE 510 MIDDLE EAST: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 352
TABLE 511 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 352
TABLE 512 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 353
TABLE 513 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 353
TABLE 514 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION) 354
TABLE 515 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 354
TABLE 516 GCC COUNTRIES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 354
TABLE 517 GCC COUNTRIES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 355
TABLE 518 GCC COUNTRIES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 355
TABLE 519 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 356
TABLE 520 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 356
TABLE 521 GCC COUNTRIES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 356
TABLE 522 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 357
TABLE 523 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 357
TABLE 524 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 358
TABLE 525 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 359
TABLE 526 SAUDI ARABIA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 359
TABLE 527 SAUDI ARABIA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 359
TABLE 528 SAUDI ARABIA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 360
TABLE 529 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 360
TABLE 530 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 361
TABLE 531 SAUDI ARABIA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 361
TABLE 532 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 362
TABLE 533 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 362
TABLE 534 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 363
TABLE 535 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 364
TABLE 536 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 364
TABLE 537 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 364
TABLE 538 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 365
TABLE 539 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 365
TABLE 540 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 366
TABLE 541 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 366
TABLE 542 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 367
TABLE 543 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 367
TABLE 544 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 368
TABLE 545 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 369
TABLE 546 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 369
TABLE 547 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 369
TABLE 548 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 370
TABLE 549 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 370
TABLE 550 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 371
TABLE 551 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 371
TABLE 552 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 372
TABLE 553 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 372
TABLE 554 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 373
TABLE 555 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 374
TABLE 556 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 374
TABLE 557 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 374
TABLE 558 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 375
TABLE 559 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 375
TABLE 560 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 376
TABLE 561 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 376
TABLE 562 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 377
TABLE 563 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 377
TABLE 564 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 378
TABLE 565 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION) 379
TABLE 566 AFRICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION) 379
TABLE 567 AFRICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION) 379
TABLE 568 AFRICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION) 380
TABLE 569 AFRICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 380
TABLE 570 AFRICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION) 381
TABLE 571 AFRICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION) 381
TABLE 572 AFRICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION) 382
TABLE 573 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION) 382
TABLE 574 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION) 383
TABLE 575 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN GENE EXPRESSION ANALYSIS MARKET, JANUARY 2023-MARCH 2026 384
TABLE 576 GENE EXPRESSION ANALYSIS MARKET: DEGREE OF COMPETITION 388
TABLE 577 GENE EXPRESSION ANALYSIS MARKET: REGION FOOTPRINT 394
TABLE 578 GENE EXPRESSION ANALYSIS MARKET: OFFERING FOOTPRINT 395
TABLE 579 GENE EXPRESSION ANALYSIS MARKET: APPLICATION FOOTPRINT 396
TABLE 580 GENE EXPRESSION ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 399
TABLE 581 GENE EXPRESSION ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 400
TABLE 582 GENE EXPRESSION ANALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026 402
TABLE 583 GENE EXPRESSION ANALYSIS MARKET: DEALS, JANUARY 2023- MARCH 2026 403
TABLE 584 GENE EXPRESSION ANALYSIS MARKET: EXPANSIONS, JANUARY 2023- MARCH 2026 403
TABLE 585 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 404
TABLE 586 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 405
TABLE 587 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026 409
TABLE 588 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023- MARCH 2026 410
TABLE 589 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023- MARCH 2026 410
TABLE 590 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 412
TABLE 591 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 414
TABLE 592 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026 417
TABLE 593 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023- MARCH 2026 418
TABLE 594 ILLUMINA, INC.: COMPANY OVERVIEW 419
TABLE 595 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED 420
TABLE 596 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026 423
TABLE 597 ILLUMINA, INC.: DEALS, JANUARY 2023- MARCH 2026 424
TABLE 598 QIAGEN: COMPANY OVERVIEW 425
TABLE 599 QIAGEN: PRODUCTS/SERVICES OFFERED 426
TABLE 600 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026 431
TABLE 601 QIAGEN: DEALS, JANUARY 2023- MARCH 2026 431
TABLE 602 REVVITY: COMPANY OVERVIEW 433
TABLE 603 REVVITY: PRODUCTS/SERVICES OFFERED 434
TABLE 604 REVVITY: DEALS, JANUARY 2023- MARCH 2026 436
TABLE 605 REVVITY: EXPANSIONS, JANUARY 2023- MARCH 2026 436
TABLE 606 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 438
TABLE 607 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED 439
TABLE 608 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026 440
TABLE 609 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2023- MARCH 2026 441
TABLE 610 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2023- MARCH 2026 441
TABLE 611 PACBIO: COMPANY OVERVIEW 442
TABLE 612 PACBIO: PRODUCTS/SERVICES OFFERED 443
TABLE 613 PACBIO: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026 444
TABLE 614 PACBIO: DEALS, JANUARY 2023- MARCH 2026 444
TABLE 615 PACBIO: EXPANSIONS, JANUARY 2023- MARCH 2026 445
TABLE 616 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 446
TABLE 617 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 447
TABLE 618 SYSMEX CORPORATION: COMPANY OVERVIEW 451
TABLE 619 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED 452
TABLE 620 SYSMEX CORPORATION: DEALS, JANUARY 2023- MARCH 2026 453
TABLE 621 SYSMEX CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023- MARCH 2026 453
TABLE 622 BGI: COMPANY OVERVIEW 454
TABLE 623 BGI: PRODUCTS/SERVICES OFFERED 454
TABLE 624 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 456
TABLE 625 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 457
TABLE 626 STANDARD BIOTOOLS: COMPANY OVERVIEW 458
TABLE 627 STANDARD BIOTOOLS: PRODUCTS/SERVICES OFFERED 459
TABLE 628 STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026 460
TABLE 629 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW 461
TABLE 630 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES OFFERED 462
TABLE 631 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2023- MARCH 2026 463
TABLE 632 OXFORD NANOPORE TECHNOLOGIES PLC: EXPANSIONS, JANUARY 2023- MARCH 2026 464
TABLE 633 GENSCRIPT: COMPANY OVERVIEW 465
TABLE 634 GENSCRIPT: PRODUCTS/SERVICES OFFERED 466
TABLE 635 GENSCRIPT: DEALS, JANUARY 2023- MARCH 2026 467
TABLE 636 GENSCRIPT: EXPANSIONS, JANUARY 2023- MARCH 2026 467
TABLE 637 TAKARA BIO INC.: COMPANY OVERVIEW 468
TABLE 638 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED 469
TABLE 639 TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026 473
TABLE 640 TAKARA BIO INC.: DEALS, JANUARY 2023- MARCH 2026 474
TABLE 641 DANAHER CORPORATION: COMPANY OVERVIEW 475
TABLE 642 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 476
TABLE 643 DANAHER CORPORATION: DEALS, JANUARY 2023- MARCH 2026 476
TABLE 644 BRUKER: COMPANY OVERVIEW 477
TABLE 645 BRUKER: PRODUCTS/SERVICES OFFERED 479
TABLE 646 BRUKER: DEALS, JANUARY 2023- MARCH 2026 479
TABLE 647 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 501
TABLE 648 RISK ASSESSMENT 502

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $4950.00
  • $6650.00
  • $8150.00
  • $10000.00
  • ADD TO BASKET
  • BUY NOW

Related Reports

NGS-Based RNA-Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product and Services (RNA Sequencing Platforms and Consumables, Sample Preparation Products, RNA Sequencing Services, Data Analysis, Storage and Management), By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing), By Application (Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), By End User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others), By Region & Competition, 2021-2031F
 Market Report I 2026-05-25 I 185 Pages
DNA Repair Drugs Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Drug Type (Alkylating Agents, PARP Inhibitors, Topoisomerase Inhibitors, Other), By Application (Neurodegenerative Diseases, Oncological, Cardiovascular Diseases, Stroke), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others), By Region & Competition, 2021-2031F
 Market Report I 2026-05-25 I 185 Pages
DNA Nanotechnology Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, Segmented By Type (Structural DNA Nanotechnology {Extended Lattices, Discrete Structures, Templated Assembly} v/s Dynamic DNA Nanotechnology {Nanomechanical Devices v/s Strand Displacement Cascades}), By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By Region & Competition, 2021-2031F
 Market Report I 2026-05-25 I 180 Pages

Don't forget we can help save time with your search, contact us and we'll prepare and send options

Genomics in Cancer Care Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Consumables, Services), By Technology (Genome Sequencing, PCR, Microarray, Nucleic Acid Extraction and Purification, Others), By Application (Diagnostics, Personalized Medicine, Drug Discovery & Development, Research), By End User (Hospitals, Research Institutes & Academic Institutes, Others), By Region & Competition, 2021-2031F
 Market Report I 2026-05-25 I 182 Pages
DNA Polymerase Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Taq Polymerase, Pfu Polymerase, Proprietary Enzyme Blends), By Application (Polymerase Chain Reaction, DNA Sequencing, DNA Cloning, Others), By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers, Others), By Region & Competition, 2021-2031F
 Market Report I 2026-05-25 I 185 Pages